Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00552578 · ClinicalTrials.gov registry record · Phase 4
Buprenorphine as a Treatment in Opiate Dependent Pain Patients
A Phase 4 study, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00552578: Clinical Trial Phase 4 study, sponsored by State University of New York at Buffalo.
NCT00552578 is a Phase 4 study that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 12 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00552578, a Phase 4 study, was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study is designed to determine if different doses of buprenorphine (either tapering doses or steady doses) are effective in managing chronic, non-cancer pain in individuals who also are addicted to opiate pain medicines.
Primary Outcome
Relapse to substance abuse (yes/no) was determined by participant self-report or by a positive urine toxicology.
Interventions
- DRUG buprenorphine/naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-10 |
| Phase | Phase 4 |
Why NCT00552578 stopped before completion
NCT00552578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which buprenorphine/naloxone is the first listed.
NCT00552578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00552578 about?
NCT00552578 is a clinical study titled "Buprenorphine as a Treatment in Opiate Dependent Pain Patients". This study is designed to determine if different doses of buprenorphine (either tapering doses or steady doses) are effective in managing chronic, non-cancer pain in individuals who also are addicted to opiate pain medicines.
What is the current status of trial NCT00552578?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2007-10. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00552578?
The interventions under investigation include: buprenorphine/naloxone (DRUG).
Who is sponsoring clinical trial NCT00552578?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00552578's enrollment target sits among peer trials
12 1913th of 2000 higher than 70 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia